Modifications to Devices Subject to Premarket Approval (PMA) - The PMA Supplement Decision-Making Process: Guidance for Industry and FDA Staff

Information

Type

Guidance

Regulated products

Biologics, Medical Devices

Topics

Premarket

Published

December 11, 2008

Last updated

February 8, 2022

Description

This document provides guidance for the decision-making process on modifications to devices subject to premarket approval (PMA).

Organization

Country / Region

United States

License

Other (Public Domain)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed